Healthcare is going through a major transition phase and is ripe for innovation, that much we know for sure. We also know that innovation comes from talented leadership, backed by smart investors.
iSelect is working with industry experts to accelerate this transition, partnering with leading medical professionals and institution to help make promising healthcare innovations a reality. Our approach is based around the simple idea that true change in health and medicine is going to come from the inside, from the doctors, researchers, and other healthcare professionals who are doing this work every day.
We want to partner with them. We want to support their ideas. We want to help their companies grow.
We work with major research centers to find the most promising opportunities, and we work with doctors to match our diligence and deal sourcing with their medical expertise to back the select few companies with the most promise. So far, this includes companies focused on chronic pain, cancer, epilepsy, pulmonary fibrosis and more.
They are the experts in healthcare. iSelect is the expert in venture investing. Together we can solve this problem.
Join our healthcare market network.
Dr. Rutter is founder and CEO of Metaphase Design Group, a design firm serving industrial, commercial and consumer product and packaging clients internationally. He is an acknowledged specialist in ergonomic product design and a leading worldwide expe …
Michael Nichols, Ph.D. presently serves as an investor and C level management for various startups. He serves as an Analyst for Vinlogx, a platform that acquires, stores, and analyses internal vehicle information enabling solutions across multiple auto …
Charles R. (Chas) Eggert has 40 years of experience in the specialty chemicals industry with a proven track record of creating value for startups and large global businesses. Chas is an operating partner focused on specialty chemical investments with A …
David Christenson joined BioGenerator as an Entrepreneur-in-Residence in 2015 focusing primarily on healthcare and specifically in information technology, care delivery and payment, and services. Over a 30-year career, David has developed substantive b …
Presently leading Arch Cancer Care as Medical Director, Dr. Beat is a local expert in collaborative prostate cancer management. At a national level, he contributes to physician leadership committees within the US Oncology Network. Having earned an exec …
Bobby Sandage is currently President and CEO of Euclises, Chairman of the board of Immunophotonics, member of the board of directors of EDIS, a member of the Cultivation Capital life sciences fund investment committee and am a member of the Selection C …
A regulatory professional with over 27 years of experience in the medical products industry, Melissa currently serves as Founder, President and CTO at Graematter, Inc. and Senior VP Regulatory at Topera. Specialties include regulatory intelligence rese …
An accomplished senior executive with start-ups, growth, and turn-around organizations, Renato developed a healthcare technology corporation, HealthTech Solutions, from a small start-up of 3 people to a national provider of technical solutions to healt …
Read More from iSelect
Fibrosis is a category of diseases that covers a lot of bases, striking everything from the lungs, to the heart, to the skin and more. And its causes are just as diverse, ranging from diabetes, to environmental factors, to genetics and even certain medications. At its...read more
Physicians have been fascinated with blood and the circulatory system for hundreds of years. Records dating back to early Roman times prove that bloodletting was in wide use as a treatment for disease at least 2,000 years ago, and leeches have been used in medicine...read more
By David Messina, PhD This is an amazing time to be in biology. In fact, I like to say that right now we’re in a place that’s a lot like where personal computers were in 1987. In those days, PCs were pretty limited in what they could do. They still ran off of floppy...read more
Cancer care is entering a new age, transitioning from treatments that attack both cancerous and healthy cells at the same time, to more targeted, specialized therapies that address the root cause of cancer itself without damaging surrounding tissues. Biotech company...read more
Obesity is the single largest health crisis facing the world today. More than one billion people worldwide are overweight or obese, accounting for 38% of the population. In the U.S., a full 68% of adults, or some 200 million people, are overweight. On average, obese...read more
There is massive consolidation occurring in the healthcare space right now, and as a result hospital systems are acting almost like private equity groups. They're sucking up all of these once-independent primary care providers and are distributing all of the...read more
For Euclises, it’s simple. Without the work of John Talley, Ph.D., the world would not have Celebrex®, the blockbuster arthritis treatment that has generated in excess of $3.5 billion in sales for Pfizer. Or Dynastat®, an injectable COX-2 inhibitor that’s sold...read more
There’s been a lot of talk this week about the EpiPen, and for good reason. First developed in the 1970s, the EpiPen is a medical device that automatically injects a measured dose of adrenaline into the bloodstream, allowing for easy field treatment of allergic...read more
It was 2008, and Jon Snyder wasn’t happy. He had spent 25 years building a career in medical device sales, specializing in products that used neurostimulation to help patients with a variety of conditions manage chronic pain. He had worked all over the world as a...read more
Idiopathic Pulmonary Fibrosis is a highly progressive and life threatening disease affects approximately 130,000 people in the United States. It’s worse than many cancers. According to the National Institute of Health, physicians are unsure of the cause, but the...read more